Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of HRTX by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−13,500−100.0%Sold outHolders
Q3 202513,500$17.0K<0.1%−18,000−57.1%ReducedHolders
Q2 202531,500$65.2K<0.1%00.0%UnchangedHolders
Q1 202531,500$69.3K<0.1%−5,500−14.9%ReducedHolders
Q4 202437,000$56.6K<0.1%−176,630−82.7%ReducedHolders
Q3 2024213,630$425.1K<0.1%−4,900−2.2%ReducedHolders
Q2 2024218,530$764.9K<0.1%+47,530+27.8%AddedHolders
Q1 2024171,000$473.7K<0.1%+140,900+468.1%AddedHolders
Q4 202330,100$51.2K<0.1%−10,500−25.9%ReducedHolders
Q3 202340,600$41.8K<0.1%−215,807−84.2%ReducedHolders
Q2 2023256,407$297.4K<0.1%+34,962+15.8%AddedHolders
Q1 2023221,445$334.4K<0.1%+47,650+27.4%AddedHolders
Q4 2022173,795$434.5K<0.1%−22,982−11.7%ReducedHolders
Q3 2022196,777$830.0K<0.1%−21,541−9.9%ReducedHolders
Q2 2022218,318$609.0K<0.1%−3,824−1.7%ReducedHolders
Q1 2022222,142$1.27M<0.1%+18,680+9.2%AddedHolders
Q4 2021203,462$1.86M<0.1%+32,760+19.2%AddedHolders
Q3 2021170,702$1.82M<0.1%+3,026+1.8%AddedHolders
Q2 2021167,676$2.60M<0.1%+44,879+36.5%AddedHolders
Q1 2021122,797$1.99M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.